Akzo Nobel N.V.
AKZOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10,711,000 | $10,668,000 | $10,846,000 | $9,587,000 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Cost of Goods Sold | $6,374,000 | $6,434,000 | $6,923,000 | $5,732,000 |
| Gross Profit | $4,337,000 | $4,234,000 | $3,923,000 | $3,855,000 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| R&D Expenses | $0 | $270,000 | $258,000 | $230,000 |
| G&A Expenses | $323,000 | $328,000 | $338,000 | $276,000 |
| SG&A Expenses | $1,563,000 | $1,538,000 | $1,531,000 | $1,296,000 |
| Sales & Mktg Exp. | $1,240,000 | $1,210,000 | $1,193,000 | $1,020,000 |
| Other Operating Expenses | $1,857,000 | $1,397,000 | $1,426,000 | $1,211,000 |
| Operating Expenses | $3,420,000 | $3,205,000 | $3,215,000 | $2,737,000 |
| Operating Income | $917,000 | $1,029,000 | $708,000 | $1,118,000 |
| % Margin | 8.6% | 9.6% | 6.5% | 11.7% |
| Other Income/Exp. Net | -$79,000 | -$245,000 | -$106,000 | -$13,000 |
| Pre-Tax Income | $838,000 | $784,000 | $602,000 | $1,105,000 |
| Tax Expense | $246,000 | $296,000 | $214,000 | $246,000 |
| Net Income | $542,000 | $442,000 | $352,000 | $829,000 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS | 3.17 | 2.61 | 2.01 | 4.48 |
| % Growth | 21.5% | 29.9% | -55.1% | – |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| Weighted Avg Shares Out | 170,800 | 169,349 | 174,735 | 184,960 |
| Weighted Avg Shares Out Dil | 171,613 | 171,339 | 175,313 | 185,874 |
| Supplemental Information | – | – | – | – |
| Interest Income | $88,000 | $95,000 | $54,000 | $35,000 |
| Interest Expense | $190,000 | $193,000 | $106,000 | $74,000 |
| Depreciation & Amortization | $371,000 | $258,000 | $362,000 | $351,000 |
| EBITDA | $1,399,000 | $1,320,000 | $1,070,000 | $1,530,000 |
| % Margin | 13.1% | 12.4% | 9.9% | 16% |